Taking into account that the overexpression of VEGF in cancers or metastases, promotes the formation of new blood vessels and, hence, tumor development, it seemed necessary to develop therapeutic methods targeting the antiangiogenic mechanism. The gene discussed is VEGFA; the disease is neoplasm.